e-learning
resources
Milan 2017
Monday, 11.09.2017
New insights into the understanding of sleep and the consequences of sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterization of IH-induced cardiac remodeling and contractile dysfunction in a rat model of post-ischemic heart failure
G. Bourdier (Grenoble, France)
Source:
International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Session:
New insights into the understanding of sleep and the consequences of sleep apnoea
Session type:
Oral Presentation
Number:
1755
Disease area:
Pulmonary vascular diseases, Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Bourdier (Grenoble, France). Characterization of IH-induced cardiac remodeling and contractile dysfunction in a rat model of post-ischemic heart failure. 1755
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Diaphragm dysfunction in isoproterenol-induced heart failure
Source: Virtual Congress 2020 – From respiratory physiology to clinical practice: exercise and respiratory muscles
Year: 2020
Role of mitochondria in the cardiac muscle from heart failure patients
Source: Annual Congress 2008 - Mitochondria in muscle-related respiratory disorders
Year: 2008
Impact of cardiac sympathetic denervation on IH-induced ischemic cardiomyopathy aggravation
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020
Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
2-Ethoxyestradiol inhibits vascular and cardiac remodeling and attenuates monocrotaline-induced pulmonary hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Zamicastat decreases cardiac arrhythmias in a rat model of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Paraquat-induced lung injury in rat presents altered pressor chemoreflex response probably due to vascular dysfunction
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
Role of cardiac function in weaning failure
Source: International Consensus Conference in Intensive Care Medicine 2005
Year: 2005
Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats
Source: Eur Respir J 2012; 40: 1420-1429
Year: 2012
Hypoxia-induced right heart failure
Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease
Year: 2006
Loss of Bmp9 does not lead to spontaneous pulmonary hypertension, but attenuates vascular remodeling in experimental models
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Moderate exercise training in monocrotaline treated rats accelerates the progression towards right ventricular heart failure
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007
Rosiglitazone impairs lung function in rats receiving isoproterenol and alone it decreases cardiac parasympathetic activity
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009
Cardiac remodelling and hemodynamic changes in pulmonary hypertension after double lung transplantation
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017
Effects of erythropoietin on advanced pulmonary vascular remodelling
Source: Eur Respir J 2008; 31: 126-134
Year: 2008
In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Theophylline increases muscle sympathetic activity in patients with congestive heart failure
Source: Annual Congress 2003 - Management of sleep related breathing disorders
Year: 2003
Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Alveolar-capillary membrane dysfunction in heart failure: histopathological changes
Source: Annual Congress 2008 - Asthma: mechanisms and treatment
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept